Xianjun Tang
Chongqing, 400030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Chidamide combined with fulvestrant in the treatment of HR-positive, HER2-negative advanced breast cancer after failure of previous endocrine therapy: a single-arm, single-center, phase 2 study.
Journal: Breast cancer research : BCR
Published: June 24, 2025
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: February 24, 2025
A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance.
Journal: Current cancer drug targets
Published: March 06, 2024
Lentinan inhibits cell invasion via M2 polarization of tumor-associated macrophages and Wnt/β-catenin signaling in non-small cell lung cancer.
Journal: Chemical biology & drug design
Published: November 02, 2023
Natural Antisense Long Noncoding RNA HHIP-AS1 Suppresses Non-Small-Cell Lung Cancer Progression by Increasing HHIP Stability via Interaction with CELF2.
Journal: Critical reviews in eukaryotic gene expression
Published: November 14, 2022
Capsule Endoscopy-Based Diagnosis of Lung Squamous Cell Carcinoma Associated with Abdominal Pain and Metastasis to Small Intestine: A Case Report.
Journal: Case reports in oncology
Published: September 28, 2022
miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression.
Journal: Gene
Published: January 09, 2019
Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial.
Journal: Neuropsychiatric disease and treatment
Published: June 27, 2018
Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: August 16, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026